Evidence map›Paper›PMID 34497655›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-

Zhiqiang Duan, Jia Yao, Nan Duan, Min Wang, Shiwei Wang

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Retracted: Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  2. Peritoneal Dialysis-Associated Peritonitis Caused byJournal of investigative medicine high impact case reports
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhiqiang DuanDepartment of Renal Disease, People's Hospital of Tang County (The Fourth Central Hospital of Baoding City), Baoding, Hebei 072350, China.ORCID https://orcid.org/0000-0003-0454-9503
Jia YaoDepartment of Renal Disease, People's Hospital of Tang County (The Fourth Central Hospital of Baoding City), Baoding, Hebei 072350, China.
Nan DuanDepartment of Geriatrics, Traditional Chinese Medicine Hospital of Wangdu County, Baoding, Hebei 072450, China.
Min WangDepartment of Renal Disease, People's Hospital of Tang County (The Fourth Central Hospital of Baoding City), Baoding, Hebei 072350, China.
Shiwei WangDepartment of Renal Disease, People's Hospital of Tang County (The Fourth Central Hospital of Baoding City), Baoding, Hebei 072350, China.
Shanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peritoneal dialysis is one of the main renal replacement treatments. However, long-term peritoneal dialysis keeps the peritoneum in contact with the sugar-containing nonphysiological peritoneal fluid, which leads to recurrent peritonitis, peritoneal fibrosis, and failure of ultrafiltration. Transforming growth factor-

Identifiers

PMID34497655
PMCPMC8421132
OpenAlexW3197886341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.